Lundbeckfond Invest A/S's Form 4 filing
Lexeo Therapeutics, Inc. (LXEO) · filed Nov 9, 2023
- Accession no.
- 0001209191-23-054907
- Filed
- Nov 9, 2023
- Trade date
- Nov 7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $2.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lundbeckfond Invest A/SCIK 0001591046 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Common Stock | CConversionAcquired | +1,321,474 | – | – | 1,321,474 | Direct | |
| Nov 7, 2023 | Common Stock | CConversionAcquired | +287,213 | – | – | 1,608,687 | Direct | |
| Nov 7, 2023 | Common Stock | PPurchaseAcquired | +227,272 | $11.00 | +$2,499,992 | 1,835,959 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Common Stock | CConversionDisposed | −1,321,474 | – | – | 0 | Direct | |
| Nov 7, 2023 | Common Stock | CConversionDisposed | −287,213 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.